About
Management
Programs
Disease
Partnering
News
Contact Orbus
PRIVACY POLICY

Orbus Therapeutics

About
Management
Programs
Disease
Partnering
News
Contact Orbus
PRIVACY POLICY
Teresa Long
August 19, 2015

Orbus Therapeutics Secures $32.5 Million Series A Financing to Advance Late-Stage Brain Cancer Drug

Teresa Long
August 19, 2015
Read Full Release
Newer PostOrbus Therapeutics Granted Orphan Drug Designation by European Medicines Agency for Late Stage Brain Cancer
Back to Top
About
Management
Board of Directors
Product Candidate
Programs
Disease
Partnering
News
Contact Us
Privacy Policy

Orbus Therapeutics  |  2479 E. Bayshore Road, Suite 105  |  Palo Alto, CA 94303  |  650-656-9440

Copyright © Orbus Therapeutics, Inc.  ALL RIGHTS RESERVED